Premier Biomedical EBIT

Premier Biomedical (BIEI) currently reports a EBIT of $-52K as of June 2026. That compares with $-59K in the prior-year period — up 10.4% year over year. That is below the sector sector average of $2.6T. Use the charts on this page to explore Premier Biomedical's EBIT history and peer comparisons.

Premier Biomedical's EBIT increased from $-59K to $-52K — a 10.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Premier Biomedical's EBIT of $-52K is lower than the its sector sector average of $2.6T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Premier Biomedical reported $-52K in EBIT as of June 2026. That compares with $-59K in the prior-year period — up 10.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-52K, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.6T. From there, open related valuation or income-statement pages for Premier Biomedical, and consider following BIEI for alerts when major investors trade the stock.